Despite a younger age at diagnosis, increased obesity, higher initial PSA levels, and shorter BCR‐free survival, AA men who underwent RP as primary treatment for PCa had non‐significantly increased survival times between BCR and metastasis and metastasis and OS, compared to CA men in an equal access healthcare system with minimal barriers to healthcare education and access. The gene discussed is BCR; the disease is obesity due to melanocortin 4 receptor deficiency.